Acutus Medical, Inc. (AFIB)

Exchange NASDAQ
0.5384


Currency in USD (Disclaimer)
Volume:
Day's Range:

AFIB Insider Trading

Transaction Date Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price(USD) Amount(USD) SEC Filing
2022-06-16 Hinrichs James F. director 19,600.0 A-Award A 19,600.0 0.50 9,870.56
2022-06-16 Hinrichs James F. director 61,311.0 A-Award A 8,400.0 0.00 0.00
2022-06-16 Marzouk Shaden director 19,600.0 A-Award A 19,600.0 0.50 9,870.56
2022-06-16 Marzouk Shaden director 12,422.0 A-Award A 8,400.0 0.00 0.00
2022-06-16 Pellegrini Niamh Louise director 19,600.0 A-Award A 19,600.0 0.50 9,870.56
2022-06-16 Pellegrini Niamh Louise director 12,572.0 A-Award A 8,400.0 0.00 0.00
2022-06-16 Huennekens R Scott director 19,600.0 A-Award A 19,600.0 0.50 9,870.56
2022-06-16 Huennekens R Scott director 8,400.0 A-Award A 8,400.0 0.00 0.00
2022-06-16 Sheridan John F director 19,600.0 A-Award A 19,600.0 0.50 9,870.56
2022-06-16 Sheridan John F director 15,947.0 A-Award A 8,400.0 0.00 0.00
2022-06-16 Cramp Daniella director 19,600.0 A-Award A 19,600.0 0.50 9,870.56
2022-06-16 Cramp Daniella director 11,623.0 A-Award A 8,400.0 0.00 0.00
2022-06-16 Bonita David P director, 10 percent owner 19,600.0 A-Award A 19,600.0 0.50 9,870.56
2022-06-16 Bonita David P director, 10 percent owner 12,422.0 A-Award A 8,400.0 0.00 0.00
2022-06-16 ElBardissi Andrew director 19,600.0 A-Award A 19,600.0 0.50 9,870.56
2022-06-16 ElBardissi Andrew director 12,422.0 A-Award A 8,400.0 0.00 0.00
2022-06-03 Huennekens R Scott director 507,509.0 S-Sale D 60,000.0 0.58 34,800.00
2022-06-01 Roman David officer: Chief Financial Officer 183,355.0 A-Award A 100,000.0 0.00 0.00
2022-04-01 Roman David officer: Chief Financial Officer 83,355.0 F-InKind D 3,248.0 1.30 4,222.40
2022-04-01 McQuillan Steven officer: SVP, Clinical Affairs & QA 45,844.0 F-InKind D 733.0 1.30 952.90
2022-04-01 Burgess Vincent J director, officer: Chief Executive Officer 61,469.0 F-InKind D 3,896.0 1.30 5,064.80
2022-02-01 Roman David officer: Chief Financial Officer 50,000.0 A-Award A 50,000.0 2.41 120,500.00
2022-02-01 Roman David officer: Chief Financial Officer 86,603.0 A-Award A 50,000.0 0.00 0.00
2022-02-01 McQuillan Steven officer: SVP, Clinical Affairs & QA 32,000.0 A-Award A 32,000.0 2.41 77,120.00
2022-02-01 McQuillan Steven officer: SVP, Clinical Affairs & QA 46,577.0 A-Award A 32,000.0 0.00 0.00
2021-11-15 Hinrichs James F. director 52,911.0 P-Purchase A 40,000.0 3.78 151,220.00
2021-08-10 Pellegrini Niamh Louise director 4,172.0 A-Award A 4,172.0 0.00 0.00
2021-08-10 Pellegrini Niamh Louise director 15,191.0 A-Award A 15,191.0 14.38 218,446.58
2021-08-05 McQuillan Steven officer: SVP, Clinical Affairs & QA 14,577.0 F-InKind D 305.0 15.52 4,733.60
2021-08-05 Burgess Vincent J director, officer: Chief Executive Officer 65,365.0 F-InKind D 1,922.0 15.52 29,829.44
2021-07-19 ORBIMED ADVISORS LLC director, 10 percent owner 4,872,025.0 P-Purchase A 714,285.0 14.00 9,999,990.00
2021-07-19 ORBIMED ADVISORS LLC director, 10 percent owner 1,677,361.0 P-Purchase A 357,143.0 14.00 5,000,002.00
2021-07-19 Bonita David P director, 10 percent owner 4,872,025.0 P-Purchase A 714,285.0 14.00 9,999,990.00
2021-07-19 Bonita David P director, 10 percent owner 1,677,361.0 P-Purchase A 357,143.0 14.00 5,000,002.00
2021-07-19 Flynn James E director, 10 percent owner, other: Director by Deputization 1,974,638.0 P-Purchase A 390,836.0 14.00 5,471,704.00
2021-07-19 Flynn James E director, 10 percent owner, other: Director by Deputization 3,438,589.0 P-Purchase A 680,592.0 14.00 9,528,288.00
2021-06-17 ElBardissi Andrew director 4,022.0 A-Award A 1,800.0 0.00 0.00
2021-06-17 ElBardissi Andrew director 7,022.0 A-Award A 7,022.0 16.66 116,986.52
2021-06-17 Bonita David P director, 10 percent owner 7,022.0 A-Award A 7,022.0 16.66 116,986.52
2021-06-17 Bonita David P director, 10 percent owner 4,022.0 A-Award A 1,800.0 0.00 0.00
2021-06-17 Flynn James E director, 10 percent owner, other: Director by Deputization 4,022.0 A-Award A 1,800.0 0.00 0.00
2021-06-17 Flynn James E director, 10 percent owner, other: Director by Deputization 7,022.0 A-Award A 7,022.0 16.66 116,986.52
2021-06-17 Hinrichs James F. director 12,911.0 A-Award A 1,800.0 0.00 0.00
2021-06-17 Hinrichs James F. director 7,022.0 A-Award A 7,022.0 0.00 0.00
2021-06-17 Malik Shahzad director 4,022.0 A-Award A 1,800.0 0.00 0.00
2021-06-17 Malik Shahzad director 7,022.0 A-Award A 7,022.0 16.66 116,986.52
2021-06-17 Marzouk Shaden director 4,022.0 A-Award A 1,800.0 0.00 0.00
2021-06-17 Marzouk Shaden director 7,022.0 A-Award A 7,022.0 16.66 116,986.52
2021-04-01 Burgess Vincent J director, officer: Chief Executive Officer 158,691.0 A-Award A 158,691.0 13.66 2,167,719.06
2021-04-01 Burgess Vincent J director, officer: Chief Executive Officer 67,287.0 A-Award A 45,065.0 0.00 0.00
2021-04-01 McQuillan Steven officer: SVP, Clinical Affairs & QA 14,882.0 A-Award A 9,882.0 0.00 0.00
2021-04-01 McQuillan Steven officer: SVP, Clinical Affairs & QA 34,800.0 A-Award A 34,800.0 13.66 475,368.00
2021-04-01 Roman David officer: Chief Financial Officer 36,603.0 A-Award A 36,603.0 0.00 0.00
2021-04-01 Roman David officer: Chief Financial Officer 77,335.0 A-Award A 77,335.0 13.66 1,056,396.10
2021-03-17 Sheridan John F director 7,547.0 A-Award A 3,147.0 0.00 0.00
2021-03-17 Sheridan John F director 10,882.0 A-Award A 10,882.0 19.06 207,410.92
2021-02-03 Cramp Daniella director 9,972.0 A-Award A 9,972.0 24.76 246,906.72
2021-02-03 Cramp Daniella director 3,223.0 A-Award A 2,423.0 0.00 0.00
2020-08-10 Hinrichs James F. director 11,111.0 P-Purchase A 10,000.0 18.00 180,000.00
2020-08-10 Flynn James E director, 10 percent owner, other: Director by Deputization 1,199,980.0 C-Conversion A 1,199,980.0 0.00 0.00
2020-08-10 Flynn James E director, 10 percent owner, other: Director by Deputization 639,358.0 C-Conversion A 189,366.0 0.00 0.00
2020-08-10 Flynn James E director, 10 percent owner, other: Director by Deputization 2,202,444.0 C-Conversion A 1,002,464.0 0.00 0.00
2020-08-10 Flynn James E director, 10 percent owner, other: Director by Deputization 1,583,802.0 P-Purchase A 944,444.0 18.00 16,999,992.00
2020-08-10 Flynn James E director, 10 percent owner, other: Director by Deputization 449,992.0 C-Conversion A 449,992.0 0.00 0.00
2020-08-10 Flynn James E director, 10 percent owner, other: Director by Deputization 2,758,000.0 P-Purchase A 555,556.0 18.00 10,000,008.00
2020-08-10 ORBIMED ADVISORS LLC director, 10 percent owner 373,500.0 P-Purchase A 373,500.0 18.00 6,723,000.00
2020-08-10 Malik Shahzad director 1,551,713.0 C-Conversion A 1,551,713.0 0.00 0.00
2020-08-10 Malik Shahzad director 0.0 C-Conversion D 10,738.0 0.00 0.00
2020-08-10 Malik Shahzad director 65,436.0 C-Conversion A 65,436.0 0.00 0.00
2020-08-10 ORBIMED ADVISORS LLC director, 10 percent owner 0.0 C-Conversion D 872,302.0 0.00 0.00
2020-08-10 ORBIMED ADVISORS LLC director, 10 percent owner 41,500.0 P-Purchase A 41,500.0 18.00 747,000.00
2020-08-10 ORBIMED ADVISORS LLC director, 10 percent owner 4,157,740.0 C-Conversion A 3,784,240.0 0.00 0.00
2020-08-10 ORBIMED ADVISORS LLC director, 10 percent owner 1,320,218.0 C-Conversion A 1,278,718.0 0.00 0.00
2020-08-10 Barnickel John officer: Chief Commercial Officer 13,966.0 P-Purchase A 7,300.0 18.00 131,400.00
2020-08-10 Flynn James E director, 10 percent owner, other: Director by Deputization 0.0 C-Conversion D 449,992.0 0.00 0.00
2020-08-10 Bonita David P director, 10 percent owner 1,320,218.0 C-Conversion A 1,278,718.0 0.00 0.00
2020-08-10 Bonita David P director, 10 percent owner 373,500.0 P-Purchase A 373,500.0 18.00 6,723,000.00
2020-08-10 Bonita David P director, 10 percent owner 41,500.0 P-Purchase A 41,500.0 18.00 747,000.00
2020-08-10 Bonita David P director, 10 percent owner 4,157,740.0 C-Conversion A 3,784,240.0 0.00 0.00
2020-08-10 Bonita David P director, 10 percent owner 0.0 C-Conversion D 872,302.0 0.00 0.00
2020-08-05 Burgess Vincent J director, officer: Chief Executive Officer 22,222.0 A-Award A 22,222.0 0.00 0.00
2020-08-05 Burgess Vincent J director, officer: Chief Executive Officer 124,542.0 A-Award A 124,542.0 0.00 0.00
2020-08-05 Hinrichs James F. director 1,111.0 A-Award A 1,111.0 0.00 0.00
2020-08-05 Malik Shahzad director 2,222.0 A-Award A 2,222.0 0.00 0.00
2020-08-05 Malik Shahzad director 12,454.0 A-Award A 12,454.0 18.00 224,172.00
2020-08-05 Hinrichs James F. director 6,227.0 A-Award A 6,227.0 18.00 112,086.00
2020-08-05 Marzouk Shaden director 2,222.0 A-Award A 2,222.0 0.00 0.00
2020-08-05 Marzouk Shaden director 12,454.0 A-Award A 12,454.0 18.00 224,172.00
2020-08-05 Doherty Gary W. officer: Chief Financial Officer 5,000.0 A-Award A 5,000.0 0.00 0.00
2020-08-05 Doherty Gary W. officer: Chief Financial Officer 28,022.0 A-Award A 28,022.0 18.00 504,396.00
2020-08-05 Barnickel John officer: Chief Commercial Officer 6,666.0 A-Award A 6,666.0 0.00 0.00
2020-08-05 Barnickel John officer: Chief Commercial Officer 153,569.0 A-Award A 153,569.0 18.00 2,764,242.00
2020-08-05 Bonita David P director, 10 percent owner 2,222.0 A-Award A 2,222.0 0.00 0.00
2020-08-05 Bonita David P director, 10 percent owner 12,454.0 A-Award A 12,454.0 18.00 224,172.00
2020-08-05 ElBardissi Andrew director 2,222.0 A-Award A 2,222.0 0.00 0.00
2020-08-05 ElBardissi Andrew director 12,454.0 A-Award A 12,454.0 18.00 224,172.00
2020-08-05 Flynn James E director, 10 percent owner, other: Director by Deputization 2,222.0 A-Award A 2,222.0 0.00 0.00
2020-08-05 Flynn James E director, 10 percent owner, other: Director by Deputization 12,454.0 A-Award A 12,454.0 18.00 224,172.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.